gladiator999 wrote:
1. A cancer drug that shows positive results in early laboratory tests
can generate a great deal of interest from cancerpatients.
Because of this interest, and the desire to make a profit
early in the development cycle, many pharmaceutical
companies rush the new drug to market as quickly as
possible. But positive early results are often misleading,
meaning that the effort to bring the drug to market was largely
wasted.Consequently, the strategy to maximize long-
term profit from a new cancer drug is to bring the drug
to market only after its positive effects are more
thoroughly tested and established
...
.jpg)
